Delivery Order SPE2DB20D9214-SPE2DB25FD4SP

Award Date 2/5/25
Potential Completion Date 2/27/25
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,974.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, with a period of performance through December 9, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $25,800.72 and has an ultimate completion date of January 10, 2025. It is for the provision of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a potential value of $17,223.68 and a completion date of March 18, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that has been awarded numerous prime and...
This is a $17,365.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,020,496 units of the prescription drug PROLASTIN C, with a June 18, 2024 completion date. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the DLA to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $17,712.00, is for the provision of 4567231023 ! PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of February 18, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,177.78, is for the procurement of 4566735277 - PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of January 3, 2025 and was awarded on December 11, 2024. DMS Pharmaceutical Group Inc. is a key...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,365.20 contract is for the delivery of PROLASTIN C 1,000 MG/20 ML vials to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,365.20 contract is for the delivery of Prolastin C, a 1,000 mg/20 ml pharmaceutical product, with a completion date of July 8, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $17,246.88, is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The contract has a completion date of February 23, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, contract 4600082013 under the SPE2DB...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide PROLASTIN C 1,000 MG/20 ML VLS. The contract has a potential value of $17,198.16 and a completion date of February 28, 2024. DMS Pharmaceutical Group is an experienced pharmaceutical wholesaler that has held multiple prime vendor contracts with the Department of Defense and Department of Veterans Affairs to supply...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB25FD4SP
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $35,424.00, is for the delivery of 4,567,231 units of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, by February 27, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of Department of Defense healthcare sites.

Generated 5/7/25, 10:01 AM